GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through the GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Genomic sequencing tests include whole genome sequencing, whole exome sequencing, prenatal genetic testing, targeted testing, pediatric neurology, general pediatrics, geneticists and genetic counsellors, and others. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Back to dashboard
Company Information
About this company
Key people
Jason Michael Ryan
Independent Chairman of the Board
Mark A. Gardner
President
Katherine A. Stueland
Chief Executive Officer and Director
Kevin Feeley
Chief Financial Officer
Bryan Dechairo
Chief Operating Officer
Eli D. Casdin
Independent Director
Thomas Fuchs
Independent Director
Emily M. Leproust
Independent Director
Keith A. Meister
Independent Director
Click to see more
Key facts
- Shares in issue29.82m
- EPICWGS
- ISINUS81663L2007
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$3.02bn
- Employees1,300
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.